文献速递头颈部肿瘤放疗放疗物理与技术

头颈部放疗急性味觉障碍的时间进程与决定因素

Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2026-04-04

这项前瞻性观察研究纳入接受≥50 Gy放疗的头颈癌患者,用无水平衡经验味觉测试(WETT)客观评估5种基本味觉。结果显示放疗期间及结束后味觉总分显著下降,鲜味和咸味受影响最大;味觉变化与舌平均剂量及口腔平均剂量相关。

要点

  • 放疗结束较基线味觉总分下降17.3%,鲜味降62.5%、咸味降30.9%。
  • 放疗后12周总分仍较基线低8.2%(P=.011),鲜味和咸味持续受影响。
  • 放疗结束时的味觉相对变化与舌平均剂量(r=-0.62)及口腔平均剂量(r=-0.58)相关。

核心结论

  • 头颈癌放疗期间及结束后患者味觉感知发生显著改变,且与舌和口腔平均剂量相关。

研究设计与样本

  • 前瞻性观察研究纳入接受≥50 Gy放疗的头颈癌患者,基线50例完成味觉测试,32例完成放疗后12周随访。
  • 采用WETT客观测量甜、酸、咸、苦、鲜5种基本味觉,评估时间点为基线、治疗中2周和4周、治疗结束及放疗后12周。
  • 采用线性回归检验时间趋势,Pearson相关分析味觉评分与临床及剂量学变量的关联。

主要发现

  • 最常见原发部位为口咽(66%)。
  • WETT总分中位数:基线20.7,2周16.2,4周17.7,治疗结束17.1,随访19。
  • 基线至治疗结束总分下降17.3%,鲜味相对变化-62.5%、咸味-30.9%。
  • 基线至随访总分相对变化-8.2%(P=.011),鲜味-50%、咸味-9.5%仍受影响最大。
  • 治疗结束相对变化与舌平均剂量(r=-0.62;P<.003)及口腔平均剂量(r=-0.58;P=.005)呈中度相关。

关键数值与推荐

  • 味觉客观评估采用WETT,覆盖甜、酸、咸、苦、鲜5种基本味觉。
  • 放疗结束较基线总分下降17.3%,鲜味降62.5%、咸味降30.9%。
  • 放疗后12周总分仍较基线低8.2%(P=.011),鲜味降50%、咸味降9.5%。
  • 治疗结束味觉相对变化与舌平均剂量r=-0.62(P<.003)、口腔平均剂量r=-0.58(P=.005)。

临床怎么用

  • 头颈癌放疗患者应关注味觉障碍,尤其鲜味和咸味,放疗期间及结束后12周仍需评估。
  • 舌和口腔平均剂量与味觉变化相关,计划设计时可关注这些剂量学参数。

局限性

  • 基线50例中仅32例完成放疗后12周随访评估。
  • 样本量有限,作者指出需未来研究和更长随访以明确味觉障碍的剂量-反应关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dysgeusia is a common toxicity experienced by patients with head and neck cancer (HNC) receiving radiation therapy (RT). In this study, we assessed the timescale of onset, progression, and recovery of dysgeusia using an objective measure. METHODS AND MATERIALS: Patients receiving RT for HNC to ≥ 50 Gy were included in this prospective observational study. The Waterless Empirical Taste Test (WETT) was used to objectively measure dysgeusia for the 5 basic tastes: sweet, sour, salty, bitter, and umami. Patients were assessed at baseline (pre-RT), 2 and 4 weeks mid-treatment, end of treatment (EOT), and 12 weeks post-RT. Changes in scores at different time points relative to baseline scores were computed. The significance of trends over time was tested using linear regression. Associations of taste scores with clinical and dosimetric variables were tested using Pearson correlation. RESULTS: Of the 50 patients who underwent baseline taste testing, 32 completed 12-week post-RT follow-up assessments. The most common primary tumor site was the oropharynx (66%). The median WETT scores were 20.7 at baseline, 16.2 at 2 weeks, 17.7 at 4 weeks, 17.1 at EOT, and 19 at follow-up. Baseline and EOT comparisons revealed a decline in total score (-17.3%), with the highest relative changes in umami (-62.5%) and salty (-30.9%). The relative total score change between baseline and follow-up was -8.2% (P = .011), demonstrating a slight improvement versus EOT, with umami (-50%) and salty (-9.5%) remaining most affected. Pearson correlations showed a moderately strong association between the EOT relative change and mean tongue dose (r: -0.62; P < .003), and oral cavity mean dose (r: -0.58; P = .005). CONCLUSIONS: This study confirms significant alterations in taste perception in patients with HNC during/after RT. Taste changes correlated with mean tongue and oral cavity doses. Future studies and longer follow-up are warranted to define dose-response relationships in dysgeusia.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yarlagadda S, Maharaj A, Nong T, et al. Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy. Adv Radiat Oncol. 2026. PMID: 42294409. doi:10.1016/j.adro.2026.102054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。